Stay updated with breaking news from William Meury. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a research note published on Thursday morning. The brokerage issued a sell rating on the stock. Several other equities analysts have also commented on the stock. HC Wainwright raised their target price on shares of Syndax Pharmaceuticals from $38.00 to $42.00 and […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its price target cut by equities researchers at Robert W. Baird from $32.00 to $28.00 in a research note issued on Tuesday, FlyOnTheWall reports. Robert W. Baird’s price target would suggest a potential upside of 107.41% from the stock’s current price. SNDX has been the subject of […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its price target hoisted by investment analysts at Guggenheim from $42.00 to $43.00 in a note issued to investors on Tuesday, FlyOnTheWall reports. Guggenheim’s target price suggests a potential upside of 218.52% from the stock’s current price. SNDX has been the subject of a number of other […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its price target lowered by Scotiabank from $39.00 to $36.00 in a research report issued on Tuesday, FlyOnTheWall reports. Scotiabank’s target price suggests a potential upside of 166.67% from the company’s current price. SNDX has been the topic of several other research reports. B. Riley upped their […]
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine analysts that are presently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued a report on the […]